|
|
|||
| |||||||||||||||||||||||||||||||||||||||
The authors explored the perplexing question of why most antibodies generated against the receptor-binding surface a highly conserved part of the HIV-1 envelope that is exposed to the immune system fail to neutralize the virus (Figure 1). They measured two types of changes that occur when individual antibodies bind to glycoprotein 120:
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved. |